Kimia Biosciences (BOM:530313) Notes Receivable: ₹0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530313 Kimia Biosciences Ltd BOM:530313
25 GF Score
Price ₹29.93
View Full Analysis

What is Kimia Biosciences Notes Receivable?

Kimia Biosciences BOM:530313 -1.42% 25 Notes Receivable is ₹0.00 Mil as of . 20. GuruFocus rates BOM:530313 with a GF Score™ of 25/100.

Kimia Biosciences's Notes Receivable for the quarter that ended in . 20 was ₹0.00 Mil.

Kimia Biosciences Notes Receivable Related Terms

Kimia Biosciences Notes Receivable Historical Data

* Premium members only.

The historical data trend for Kimia Biosciences's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kimia Biosciences Notes Receivable Chart

Kimia Biosciences Annual Data
Trend
Notes Receivable

Kimia Biosciences Semi-Annual Data
Notes Receivable
BOM:530313
25GF Score
Kimia Biosciences Ltd BOM:530313
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kimia Biosciences Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ₹0.00 Mil mean?
Kimia Biosciences (BOM:530313) has a Notes Receivable of ₹0.00 Mil as of . 20. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Kimia Biosciences and its competitors.
Is Kimia Biosciences' Notes Receivable too high?
Kimia Biosciences' current Notes Receivable is ₹0.00 Mil. Overall, Kimia Biosciences has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Kimia Biosciences' Notes Receivable compare to ZTS?
Kimia Biosciences' Notes Receivable of ₹0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Drug Manufacturers company?
A good Notes Receivable depends on the Drug Manufacturers industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Kimia Biosciences and its competitors. Kimia Biosciences's current Notes Receivable is ₹0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kimia Biosciences stock overvalued right now?
Kimia Biosciences (BOM:530313) has a current Notes Receivable of ₹0.00 Mil. The current Notes Receivable is ₹0.00 Mil. Kimia Biosciences' overall GF Score™ is 25/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Kimia Biosciences (BOM:530313), the current Notes Receivable is ₹0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kimia Biosciences Business Description

Address Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034
Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Prucalopride, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.
25GF Score

Get the complete analysis for BOM:530313

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹29.93
Price